Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts-Reference-Cited by-同舟云学术

Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts

Published:2021-02 Issue:2 Volume:10 Page:2018-2026
ISSN:2224-5820
Container-title:Annals of Palliative Medicine
language:
Short-container-title:Ann Palliat Med

Author:

Li Juan,He Jing,Cai Linbo,Lai Mingyao,Hu Qingjun,Ren Chen,Wen Lei,Wang Jian,Zhou Jiangfen,Zhou Zhaoming,Li Shaoqun,Ye Minting,Shan Changguo,Chen Longhua,Zhou Cheng

Publisher

AME Publishing Company

Subject

Anesthesiology and Pain Medicine,Advanced and Specialized Nursing

Link

https://apm.amegroups.com/article/download/62065/pdf

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect of melatonin against radiobiological damage in the brain of rats exposed to low and high dose rate radiotherapy;Radiation Physics and Chemistry;2024-11

2. The incidence and predictive factors of secondary epilepsy in patients with supratentorial brain metastases (st-BMs) after stereotactic radiosurgery: A multicenter retrospective study;Epilepsy & Behavior;2024-08

3. Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy;BMC Cancer;2024-07-30

4. Efficacy and safety of combined anti-vascular and two-staged stereotactic radiosurgery therapy for brain metastases with brainstem compression: a retrospective multicenter study;2024-06-10

5. Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis;Journal of Neuro-Oncology;2024-04-15